<HashMap><database>biostudies-literature</database><scores/><additional><submitter>Copeland RA</submitter><funding>Basic Energy Sciences</funding><funding>National Institute of General Medical Sciences</funding><funding>NIGMS NIH HHS</funding><pagination>2293-2303</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC7962147</full_dataset_link><repository>biostudies-literature</repository><omics_type>Unknown</omics_type><volume>143(5)</volume><pubmed_abstract>Ethylene-forming enzyme (EFE) is an ambifunctional iron(II)- and 2-oxoglutarate-dependent (Fe/2OG) oxygenase. In its major (EF) reaction, it converts carbons 1, 2, and 5 of 2OG to CO&lt;sub>2&lt;/sub> and carbons 3 and 4 to ethylene, a four-electron oxidation drastically different from the simpler decarboxylation of 2OG to succinate mediated by all other Fe/2OG enzymes. EFE also catalyzes a minor reaction, in which the normal decarboxylation is coupled to oxidation of l-arginine (a required activator for the EF pathway), resulting in its conversion to l-glutamate semialdehyde and guanidine. Here we show that, consistent with precedent, the l-Arg-oxidation (RO) pathway proceeds via an iron(IV)-oxo (ferryl) intermediate. Use of 5,5-[&lt;sup>2&lt;/sup>H&lt;sub>2&lt;/sub>]-l-Arg slows decay of the ferryl complex by >16-fold, implying that RO is initiated by hydrogen-atom transfer (HAT) from C5. That this large substrate deuterium kinetic isotope effect has no impact on the EF:RO partition ratio implies that the same ferryl intermediate cannot be on the EF pathway; the pathways must diverge earlier. Consistent with this conclusion, the variant enzyme bearing the Asp191Glu ligand substitution accumulates ∼4 times as much of the ferryl complex as the wild-type enzyme and exhibits a ∼40-fold diminished EF:RO partition ratio. The selective detriment of this nearly conservative substitution to the EF pathway implies that it has unusually stringent stereoelectronic requirements. An active-site, like-charge guanidinium pair, which involves the l-Arg substrate/activator and is unique to EFE among four crystallographically characterized l-Arg-modifying Fe/2OG oxygenases, may serve to selectively stabilize the transition state leading to the unique EF branch.</pubmed_abstract><journal>Journal of the American Chemical Society</journal><pubmed_title>An Iron(IV)-Oxo Intermediate Initiating l-Arginine Oxidation but Not Ethylene Production by the 2-Oxoglutarate-Dependent Oxygenase, Ethylene-Forming Enzyme.</pubmed_title><pmcid>PMC7962147</pmcid><funding_grant_id>4R00GM129460</funding_grant_id><funding_grant_id>DE-SC0016255</funding_grant_id><funding_grant_id>P30 GM124169</funding_grant_id><funding_grant_id>R00 GM129460</funding_grant_id><pubmed_authors>Bollinger JM</pubmed_authors><pubmed_authors>Shoda TKC</pubmed_authors><pubmed_authors>Davis KM</pubmed_authors><pubmed_authors>Krebs C</pubmed_authors><pubmed_authors>Copeland RA</pubmed_authors><pubmed_authors>Blaesi EJ</pubmed_authors><pubmed_authors>Boal AK</pubmed_authors></additional><is_claimable>false</is_claimable><name>An Iron(IV)-Oxo Intermediate Initiating l-Arginine Oxidation but Not Ethylene Production by the 2-Oxoglutarate-Dependent Oxygenase, Ethylene-Forming Enzyme.</name><description>Ethylene-forming enzyme (EFE) is an ambifunctional iron(II)- and 2-oxoglutarate-dependent (Fe/2OG) oxygenase. In its major (EF) reaction, it converts carbons 1, 2, and 5 of 2OG to CO&lt;sub>2&lt;/sub> and carbons 3 and 4 to ethylene, a four-electron oxidation drastically different from the simpler decarboxylation of 2OG to succinate mediated by all other Fe/2OG enzymes. EFE also catalyzes a minor reaction, in which the normal decarboxylation is coupled to oxidation of l-arginine (a required activator for the EF pathway), resulting in its conversion to l-glutamate semialdehyde and guanidine. Here we show that, consistent with precedent, the l-Arg-oxidation (RO) pathway proceeds via an iron(IV)-oxo (ferryl) intermediate. Use of 5,5-[&lt;sup>2&lt;/sup>H&lt;sub>2&lt;/sub>]-l-Arg slows decay of the ferryl complex by >16-fold, implying that RO is initiated by hydrogen-atom transfer (HAT) from C5. That this large substrate deuterium kinetic isotope effect has no impact on the EF:RO partition ratio implies that the same ferryl intermediate cannot be on the EF pathway; the pathways must diverge earlier. Consistent with this conclusion, the variant enzyme bearing the Asp191Glu ligand substitution accumulates ∼4 times as much of the ferryl complex as the wild-type enzyme and exhibits a ∼40-fold diminished EF:RO partition ratio. The selective detriment of this nearly conservative substitution to the EF pathway implies that it has unusually stringent stereoelectronic requirements. An active-site, like-charge guanidinium pair, which involves the l-Arg substrate/activator and is unique to EFE among four crystallographically characterized l-Arg-modifying Fe/2OG oxygenases, may serve to selectively stabilize the transition state leading to the unique EF branch.</description><dates><release>2021-01-01T00:00:00Z</release><publication>2021 Feb</publication><modification>2026-04-16T15:06:06.137Z</modification><creation>2026-04-07T14:13:25.382Z</creation></dates><accession>S-EPMC7962147</accession><cross_references><pubmed>33522811</pubmed><doi>10.1021/jacs.0c10923</doi></cross_references></HashMap>